Login | Register
Profile | Log out
logo

  • Home
  • News
  • Opinion
  • Other
    • Market Updates
    • Explainers
    • Satire
  • About
  • Contact Us
    • Contact
    • Get Covered
    • Posting Guidelines
  • Subscribe
Submit An Article

cannabis

  • Home
  •  
  • cannabis



  • Most Read
  • Latest Comments
  • Top cannabis grower enters production deal with THC Global
    • News

    RBA and ASIC up the ante on blockchain project, ASX writes off millions
    Public
  • Top cannabis grower enters production deal with THC Global
    • News

    AV uptake leads Audinate to push European expansion through recruiting drive
    Public
  • Top cannabis grower enters production deal with THC Global
    • Opinion

    What the SportsBet-BetEasy merger means for TabCorp and punters
    Public
  • Top cannabis grower enters production deal with THC Global
    • News

    Why this Tasmanian whisky brand had a record sales quarter
    Public
  • Top cannabis grower enters production deal with THC Global
    Tremors from the FTX collapse continue to be felt as DigitalX sells off 15% Bitcoin holdings
    • Review
    • January 10, 2023
  • Opening a new frontier in treating Parkinson’s disease
    • Review
    • November 11, 2022
  • AUDC stablecoin gathers momentum as Novatti confirms integration with XRP Ledger
    • Review
    • June 9, 2022
  • PharmAust completes dosing first cohort for MND treatment, patients respond positively
    • Review
    • January 6, 2023
  • Is this the most hated company on the ASX?
    • Review
    • August 16, 2019

Latest Articles

  • ECS Botanics secures distribution rights to bring Terphogz’s ‘The Original Z’ cannabis strain to Australia
    ECS Botanics secures distribution rights to bring Terphogz’s ‘The Original Z’ cannabis strain to Australia
    • News

  • Bioxyne leads the way as Australia’s first manufacturer of pharmaceutical cannabis gummies
    Bioxyne leads the way as Australia’s first manufacturer of pharmaceutical cannabis gummies
    • News

  • Melodiol moves to clear debt with $12m asset fire sale
    Melodiol moves to clear debt with $12m asset fire sale
    • News

  • Althea to make a splash in the US with new cannabis-based sodas
    Althea to make a splash in the US with new cannabis-based sodas
    • News

  • Melodiol Global Health reports revenue growth amid wider acceptance of medicinal cannabis products
    Melodiol Global Health reports revenue growth amid wider acceptance of medicinal cannabis products
    • News

  • Top cannabis grower enters production deal with THC Global
    • News

    Top cannabis grower enters production deal with THC Global

    In preparation for legislative changes which may soon see cannabis products purchasable over the counter without a prescription, leading medicinal cannabis product manufacturer THC Global (ASX: THC) has partnered with Cannatrek to produce white-labeled CBD products at their high-volume Southport facility in Queensland.  As a sizable grower of medicinal cannabis with a diverse range of

    Read More
    Public
  • Researchers choose LumiGrow for horticulture studies, Enevis continues turnaround
    • News

    Researchers choose LumiGrow for horticulture studies, Enevis continues turnaround

    Australian tech company Enevis (ASX: ENE) has continued an impressive business turnaround which has led to three leading Universities electing to conduct horticulture research using LumiGrow lighting solutions which recently won the Best Lighting Solutions award at the 2019 Canadian Cannabis awards.  Having secured exclusive distribution rights from U.S company LumiGrow, orders were placed with

    Read More
    Public
  • THC Global secures permit to commence medicinal cannabis manufacturing in Queensland
    • News

    THC Global secures permit to commence medicinal cannabis manufacturing in Queensland

    Australian cannabis pharmaceuticals company THC Global (ASX: THC) is one major step closer to their ‘Farm to Pharma’ strategy, having been granted a Manufacture Permit from the Australian Office of Drug Control for their facility in Southport, Queensland.  By securing the permit, THC Global will immediately commence production of medicinal cannabis products which have been

    Read More
    Public
  • Zelda to launch clinical trials testing cannabis as solution to insomnia
    • News

    Zelda to launch clinical trials testing cannabis as solution to insomnia

    Australian bio-pharmaceutical developer Zelda Therapeutics (ASX: ZLD) has now fully enrolled insomnia sufferers into clinical trials where the Company aims to use cannabis as a treatment for clinically diagnosed patients.  This set of trials will be completed in collaboration with the University of Western Australia (UWA) Centre for Sleep Science. The trials will aim to

    Read More
    Public
  • Cann Global launches Asian operations to capitalise on hemp-friendly climate
    • News

    Cann Global launches Asian operations to capitalise on hemp-friendly climate

    Medical cannabis producer, Cann Global (ASX: CGB) is set to expand their operations in Asia after launching a new Asian-based subsidiary, allowing them to cultivate and process cannabinoid products in South-East Asia.  By commencing operation in south-east Asia, the Company is best positioned to capitalise on conditions which are ideal for outdoor growing, which may

    Read More
    Public
  • Roots’ central heating pipes increase cannabis yield by 40%
    • News

    Roots’ central heating pipes increase cannabis yield by 40%

    Installation of agriculture tech company Roots’ (ASX: ROO) soil heating system has seen cannabis yields increase by 40%, applying a similar heating system to root soils which humans have been implementing in homes for decades.  The Root Zone Technology Optimization (RTZO) technology sees Roots install piping within soil depths which enable users to control the

    Read More
    Public
  • «
  • ‹
  • 7
  • 8
  • 9
  • 10
  • ›

Login or register for free to access unlimited reading

Register Now!
  • News

  • Opinion

  • Satire

  • About

  • Contact Us

  • Subscribe

The content published on this website is solely for general information purposes and is not to be construed as financial advice. Should you seek financial advice you should consult with an appropriately qualified person. Opinions expressed on this site are subject to change without notice and The Sentiment who produced this content is under no obligation to keep the information current. The Sentiment, affiliated companies & associates may have a conflict of interest with companies discussed on the website due to commercial arrangements, for example they may be shareholders in the company, be engaged by them to assist in investor communications or receive commission/brokerage for funds raised.

Copyright © 2020 The Sentiment. All rights reserved.
Subscribe

Enter your email address below to subscribe to The Sentiment’s weekly newsletter, highlighting the top news, research, opinion and satire articles shaping ASX investor sentiment.

The Sentiment respects your privacy and will not spam you. View our privacy policy here.